Evolution of the Average Target: Cerence Inc.

Evolution of the Target Price: Cerence Inc.

Changes in Analyst Recommendations: Cerence Inc.

f5e2535.pkBg93teUWPrO4EFYO806WMk4zzfSUXLlc_vA685LSo.8wUGwR0uZRLdYc9LBdxDvlFDqUasLiqGw4e6Zp5XSnnJcBWwIWY1LLJ-5g~0602ade1ea0b88309af104ac245b4a32
02/04 Cantor Fitzgerald Initiates Cerence at Overweight With $11 Price Target MT
07/08/25 Cerence Q3 revenue beats expectations RE
22/01/25 Needham Upgrades Cerence to Buy From Hold, $16 Price Target MT
15/07/24 Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating MT
13/07/24 Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating MT
11/05/24 Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating MT
10/05/24 Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating MT
10/05/24 Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50 MT
17/04/24 Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating MT
08/02/24 Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating MT
08/02/24 Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22 MT
30/11/23 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating MT
30/11/23 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept MT
29/11/23 Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating MT
28/11/23 Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating MT
28/11/23 Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating MT
09/08/23 Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating MT
11/05/23 Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating MT
11/05/23 Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating MT
10/02/23 Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating MT
10/02/23 Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating MT
10/02/23 Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating MT
10/02/23 Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating MT
10/02/23 Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating MT
10/02/23 Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.58%
+14.97%
+10.14%
+11.63%
+24.28%
+33.1%
+26.91%
+16.17%
+15.85%
+4.99%
Average +17.76%
Weighted average by Cap. +15.10%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
8.990USD
Average target price
10.75USD
Spread / Average Target
+19.58%
High Price Target
12.00USD
Spread / Highest target
+33.48%
Low Price Target
9.000USD
Spread / Lowest Target
+0.11%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Cantor Fitzgerald
Needham & Co.
Wells Fargo Securities
Wedbush
Baird
Craig-Hallum
Goldman Sachs
Jefferies & Co.
Cowen
RBC Capital Markets
Berenberg Bank
Raymond James
Evercore ISI
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
8.990USD
Average target price
10.75USD
Spread / Average Target
+19.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRNC Stock
  4. Consensus Cerence Inc.